Farxiga and Photodermatosis - a phase IV clinical study of FDA data
Photodermatosis is reported only by a few people who take Farxiga.
The phase IV clinical study analyzes which people take Farxiga and have Photodermatosis. It is created by eHealthMe based on reports of 14,198 people who have side effects while taking Farxiga from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
14,198 people reported to have side effects when taking Farxiga.
Among them, 2 people (0.01%) have Photodermatosis.
What is Farxiga?
Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. eHealthMe is studying from 14,510 Farxiga users for its effectiveness, alternative drugs and more.
What is Photodermatosis?
Photodermatosis (skin disease that is caused by exposure to sunlight) is found to be associated with 333 drugs and 166 conditions by eHealthMe.
Number of Farxiga and Photodermatosis reports submitted per year:
Gender of people who have Photodermatosis when taking Farxiga *:
- female: 100 %
- male: 0.0 %
Age of people who have Photodermatosis when taking Farxiga *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common side effects people have besides Photodermatosis *:
- Weight Decreased: 2 people, 100.00%
- Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin)): 2 people, 100.00%
- Fungal Infection: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Farxiga and have Photodermatosis?Check whether Photodermatosis is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Photodermatosis and when was it recovered:
Expand to all the drugs that have ingredients of dapagliflozin:
Alternative drugs to, pros and cons of Farxiga:
- Farxiga (14,510 reports)
Common Farxiga side effects:
- Weight decreased: 733 reports
- Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 549 reports
- Dizziness: 469 reports
- Fatigue (feeling of tiredness): 436 reports
- Urinary tract infection: 433 reports
- Death: 382 reports
Browse all side effects of Farxiga:a b c d e f g h i j k l m n o p q r s t u v w x y z
Photodermatosis treatments and more:
- Photodermatosis (660 reports)
COVID vaccines that are related to Photodermatosis:
- Photodermatosis in Moderna COVID Vaccine
- Photodermatosis in Pfizer BioNTech Covid Vaccine
- Photodermatosis in Johnson and Johnson Covid Vaccine
Common drugs associated with Photodermatosis:
- Prednisone: 152 reports
- Voriconazole: 140 reports
- Tacrolimus: 115 reports
- Pantoprazole: 113 reports
- Mycophenolate mofetil: 101 reports
All the drugs that are associated with Photodermatosis:
- Photodermatosis (334 drugs)
All the conditions that are associated with Photodermatosis:
- Photodermatosis (166 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on dapagliflozin (the active ingredients of Farxiga) and Farxiga (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Calcium Acetate and Atenolol drug interaction - 10 seconds ago
- Ofev and Yellow Skin - 10 seconds ago
- Tramadol Hydrochloride And Acetaminophen vs. Lamictal - 14 seconds ago
- Abdominal Pain and Salivary Gland Mass - 19 seconds ago
- Testosterone Cypionate and Wheezing - 26 seconds ago
- Fexofenadine Hydrochloride and Abdominal Pain - 31 seconds ago
- Inbrija and Limb Injury - 34 seconds ago
- Restoril and Anovulatory Cycle - 38 seconds ago
- Selzentry and Tendon Rupture - 40 seconds ago
- Probiotic and Benicar drug interaction - 51 seconds ago